Stable suppository formulations effecting bioavailability of Ɗ9 -THC
Patent 5508037 Issued on April 16, 1996. Estimated Expiration Date: 
February 2, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 2, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3728360 Method for effecting systemic delivery of delta-9-tetrahydrocannabinol Patent #: 4933363 InventorAssigneeApplicationNo. 382500 filed on 02/02/1995US Classes:424/436, Anal, rectal (e.g., suppositories, etc.)514/786, Glyceride514/966RECTALExaminersPrimary: Azpuru, CarlosAttorney, Agent or FirmInternational ClassesA61K 009/02A61K 047/44 AbstractSuppository formulations having long-term stability and containing readily bioavailable Ɗ9 -THC derivatives. | |
